Expert Review of Vaccines, Volume 23, Issue 1 (2024)

Browse this journal

Expert Review of Vaccines, Volume 23, Issue 1 (2024)

See all volumes and issues
Volume 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs

Issue In Progress

Editorial

Editorial
Tackling vaccine inequity in 2023: have we made progress?
Els Torreele
Pages: 1-4
Published online: 11 Dec 2023
First Page PreviewforTackling vaccine inequity in 2023: have we made progress? | Full Text | References | PDF (2.4 MB) | EPUB
  • 1338 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Progress toward the development of Lassa vaccines
Hinh Ly
Pages: 5-7
Published online: 11 Dec 2023
First Page PreviewforProgress toward the development of Lassa vaccines | Full Text | References | PDF (141.2 KB) | EPUB
  • 785 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons in Italy
Francesco Lapi, Ettore Marconi, Elettra Fallani, Marco Salvatore, Maura Cambiaggi, Alessandro Rossi & Claudio Cricelli
Pages: 8-15
Published online: 11 Dec 2023
AbstractforTime lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons in Italy | Full Text | References | PDF (632 KB) | EPUB | Supplemental
  • 680 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore
Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Bulent Taysi, Josie Dodd, Ben Yarnoff & Helen M Oh
Pages: 16-26
Published online: 12 Dec 2023
AbstractforModelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 911 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable
Chiara de Waure, Barbara C. Gärtner, Pier Luigi Lopalco, Joan Puig-Barbera & Jonathan S. Nguyen-Van-Tam
Pages: 27-38
Published online: 12 Dec 2023
AbstractforReal world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable | Full Text | References | PDF (917.3 KB) | EPUB
  • 1201 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Influenza B virus neuraminidase: a potential target for next-generation vaccines?
Thi Hoai Thu Do, Adam K. Wheatley, Stephen J. Kent & Marios Koutsakos
Pages: 39-48
Published online: 14 Dec 2023
AbstractforInfluenza B virus neuraminidase: a potential target for next-generation vaccines? | Full Text | References | PDF (1.3 MB) | EPUB
  • 1743 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Editorial

Editorial
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
Elizabeth Adrianne Hammershaimb & Andrea A. Berry
Pages: 49-52
Published online: 14 Dec 2023
First Page PreviewforPre-erythrocytic malaria vaccines: RTS,S, R21, and beyond | Full Text | References | PDF (183.6 KB) | EPUB
  • 1424 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
Yiming Li, Sori K Lundin, Jianfu Li, Wei Tao, Yifang Dang, Yong Chen & Cui Tao
Pages: 53-59
Published online: 14 Dec 2023
AbstractforUnpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data | Full Text | References | PDF (575 KB) | EPUB | Supplemental
  • 1398 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children
Josiah Ryman, Jeffrey R. Sachs, Ka Lai Yee, Natalie Banniettis, Jessica Weaver & Thomas Weiss
Pages: 60-68
Published online: 14 Dec 2023
AbstractforPredicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2542 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses
Jiamin Qiu, Shiwen Zhang, Yonghui Feng, Xin Su, Jun Cai, Shiyun Chen, Jiazi Liu, Shiqi Huang, Haokun Huang, Sui Zhu, Huiyan Wen, Jiaxin Li, Haoyu Yan, Zhiquan Diao, Xiaofeng Liang & Fangfang Zeng
Pages: 69-81
Published online: 14 Dec 2023
AbstractforEfficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 1703 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
Stephen I. Pelton, Joaquin F. Mould-Quevedo & Van Hung Nguyen
Pages: 82-87
Published online: 14 Dec 2023
AbstractforModelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US | Full Text | References | PDF (231.9 KB) | EPUB | Supplemental
  • 1004 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity
Laura Colombo, Sanjay Hadigal, Jos Nauta, Alona Kondratenko, Jutta Rogoll & Serge van de Witte
Pages: 88-101
Published online: 15 Dec 2023
AbstractforInfluvac Tetra: clinical experience on safety, efficacy, and immunogenicity | Full Text | References | PDF (526.1 KB) | EPUB
  • 2097 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
The use of electroporation to deliver DNA-based vaccines
Denis N Kisakov, Igor M. Belyakov, Lubov A Kisakova, Vladimir A Yakovlev, Elena V Tigeeva & Larisa I Karpenko
Pages: 102-123
Published online: 18 Dec 2023
AbstractforThe use of electroporation to deliver DNA-based vaccines | Full Text | References | PDF (1.1 MB) | EPUB
  • 1483 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons
Myron J. Levin, Victoria Divino, Maarten J. Postma, Stephen I. Pelton, Zifan Zhou, Mitch DeKoven & Joaquin Mould-Quevedo
Pages: 124-136
Published online: 19 Dec 2023
AbstractforA clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1081 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
Timothy J Chapman, Liset Olarte, Ghassan Dbaibo, Avril Melissa Houston, Gretchen Tamms, Robert Lupinacci, Kristen Feemster, Ulrike K Buchwald & Natalie Banniettis
Pages: 137-147
Published online: 20 Dec 2023
AbstractforPCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children | Full Text | References | PDF (357.2 KB) | EPUB
  • 2112 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-analysis

Review Article
Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials
Juntao Yin, Liang Zhang, Chaoyang Wang, Changjiang Qin & Mingsan Miao
Pages: 148-159
Published online: 22 Dec 2023
AbstractforImmunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 1057 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate
Richard Thomson-Luque, Thomas C Stabler, Kristin Fürle, Joana C Silva & Claudia Daubenberger
Pages: 160-173
Published online: 27 Dec 2023
AbstractforPlasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 1306 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
Syamala R. Thimmiraju, Jason T. Kimata & Jeroen Pollet
Pages: 174-185
Published online: 03 Jan 2024
AbstractforPseudoviruses, a safer toolbox for vaccine development against enveloped viruses | Full Text | References | PDF (1 MB) | EPUB
  • 1448 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Modeling undetected poliovirus circulation following the 2022 outbreak in the United States
Dominika A. Kalkowska, Kamran Badizadegan, Janell A. Routh, Cara C. Burns, Eli S. Rosenberg, I. Ravi Brenner, Jane R. Zucker, Marisa Langdon-Embry & Kimberly M. Thompson
Pages: 186-195
Published online: 04 Jan 2024
AbstractforModeling undetected poliovirus circulation following the 2022 outbreak in the United States | Full Text | References | PDF (2.6 MB) | EPUB
  • 767 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Multiple antigen presenting system (MAPS): state of the art and potential applications
Richard Malley, Ying-Jie Lu, Shite Sebastian, Fan Zhang & David O. Willer
Pages: 196-204
Published online: 08 Jan 2024
AbstractforMultiple antigen presenting system (MAPS): state of the art and potential applications | Full Text | References | PDF (2 MB) | EPUB
  • 2708 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Neoadjuvant personalized cancer vaccines: the final frontier?
Guilhem Richard, Nicole Ruggiero, Gary D. Steinberg, William D. Martin & Anne S. De Groot
Pages: 205-212
Published online: 10 Jan 2024
AbstractforNeoadjuvant personalized cancer vaccines: the final frontier? | Full Text | References | PDF (996.2 KB) | EPUB
  • 1482 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Shingo Masuda, Ryosuke Osawa, Naoto Hosokawa, Kei Nakashima, Hiroshi Kamura, Haruki Imura, Hiroki Inoue, Suguru Matsuzaka, Yukihiro Sugimoto, Osamu Kuwamitsu, Iori Motohashi, Toru Morikawa, Rentaro Oda, Yuiko Hoshina, Takashi Matono, Osamu Teshigahara, Eiichiro Sando, Sadaharu Asami, Satoshi Kudo, Noboru Akizuki, Yoshikazu Muto, Tomoichiro Hayakawa, Tomoo Kishaba, Yasuji Ohara, Yoshinao Kubo, Motoi Suzuki & Konosuke Morimoto
Pages: 213-225
Published online: 08 Feb 2024
AbstractforEffectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS) | Full Text | References | PDF (4.9 MB) | EPUB | Supplemental
  • 1103 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data
Jörg Schelling, Suzanne Einmahl, Ralph Torgler & Carsten Schade Larsen
Pages: 226-236
Published online: 16 Feb 2024
AbstractforEvidence for a 10-year TBE vaccine booster interval: an evaluation of current data | Full Text | References | PDF (1 MB) | EPUB
  • 863 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study
Xiang Guo, Juan Li, Jing Qiu, Rui Zhang, Jia Ren, Zhuoying Huang, Zhi Li, Xiufang Liang, Fang Lan, Juan Chen, Fang Huang & Xiaodong Sun
Pages: 237-245
Published online: 19 Feb 2024
AbstractforPersistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 404 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Combatting infectious diarrhea: innovations in treatment and vaccination strategies
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Nikita Sharma, Swati Punetha, Anand Sairam, Dixa Vaghela, Narges Dargahi & Vasso Apostolopoulos
Pages: 246-265
Published online: 19 Feb 2024
AbstractforCombatting infectious diarrhea: innovations in treatment and vaccination strategies | Full Text | References | PDF (3 MB) | EPUB
  • 1201 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-analysis

Review Article
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
Alberto San Francisco Ramos, Carolina Liu Sanchez, Tatiana Bovill Rose, David Smith, Natasha Thorn, Eva Galiza, Thahmena Miah, Jennifer Pearce, Cecilia Hultin, Catherine Cosgrove, Yingfen Hsia & Paul T. Heath
Pages: 266-282
Published online: 26 Feb 2024
AbstractforComparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis | Full Text | References | PDF (4.2 MB) | EPUB | Supplemental
  • 1056 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira & Punnee Pitisuttithum
Pages: 283-293
Published online: 27 Feb 2024
AbstractforEffect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine | Full Text | References | PDF (604.6 KB) | EPUB
  • 694 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Comment
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect
James J Bull, Scott L Nuismer, Christopher H Remien, Megan E Griffiths & Rustom Antia
Pages: 294-302
Published online: 28 Feb 2024
AbstractforRecombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect | Full Text | References | PDF (517.6 KB) | EPUB | Supplemental
  • 452 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho & Ataru Igarashi
Pages: 303-311
Published online: 01 Mar 2024
AbstractforThe potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis | Full Text | References | PDF (963.2 KB) | EPUB
  • 1693 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
Cody Palmer, Christiaan Dolk, Ugne Sabale, Wei Wang & Kunal Saxena
Pages: 312-323
Published online: 01 Mar 2024
AbstractforCost-effectiveness of nonavalent HPV vaccination in the Netherlands | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 867 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives
Ugne Sabale, Janice Murtagh, James Cochrane, Danielle Riley, Richard Perry, Louise Heron, Paolo Bonanni, Jose Navarro Alonso, Juhani Eskola & Valerie Laigle
Pages: 324-335
Published online: 01 Mar 2024
AbstractforAssessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 570 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir & Mohammad Mir
Pages: 336-348
Published online: 01 Mar 2024
AbstractforThe mRNA vaccine, a swift warhead against a moving infectious disease target | Full Text | References | PDF (2.5 MB) | EPUB
  • 1438 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada & Naohiro Yonemoto
Pages: 349-361
Published online: 05 Mar 2024
AbstractforCost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 884 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines
Xuanxuan Zhang, Jialu Zhang, Si Chen, Qian He, Yu Bai, Jianyang Liu, Zhongfang Wang, Zhenglun Liang, Ling Chen, Qunying Mao & Miao Xu
Pages: 362-370
Published online: 12 Mar 2024
AbstractforProgress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines | Full Text | References | PDF (940.3 KB) | EPUB
  • 663 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
Ian McGovern, Alexandra Taylor, Aditya Sardesai, Hector Toro-Diaz & Mendel Haag
Pages: 371-379
Published online: 18 Mar 2024
AbstractforInfluenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine | Full Text | References | PDF (5.2 MB) | EPUB | Supplemental
  • 496 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection
Alexander Domnich, Andrea Orsi, Alessio Signori, Maria Chironna, Ilaria Manini, Christian Napoli, Caterina Rizzo, Donatella Panatto & Giancarlo Icardi
Pages: 380-388
Published online: 18 Mar 2024
AbstractforWaning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection | Full Text | References | PDF (300.9 KB) | EPUB | Supplemental
  • 492 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
The durability of vaccine-induced protection: an overview
Vipin M. Vashishtha & Puneet Kumar
Pages: 389-408
Published online: 20 Mar 2024
AbstractforThe durability of vaccine-induced protection: an overview | Full Text | References | PDF (1.7 MB) | EPUB
  • 2526 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
Hua Shi & Ted M. Ross
Pages: 409-418
Published online: 25 Mar 2024
AbstractforInactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine | Full Text | References | PDF (1.2 MB) | EPUB
  • 834 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
Abundio Balgos, Suad Hannawi, Wen-Li Chen, Alaa Abuquta, Linda Safeldin, Aala Hassan, Ahmad Alamadi, Louie Tirador, Anjuli May Jaen, Ralph Elvi Villalobos, Chen Mo, Zi-Jing Yue, Ying Ma, Qing-Shuang Wang, Ren-Du Wen, Zheng Yao, Jia-Ping Yu, Wen-Rong Yao, Jian-Hui Zhang, Kun-Xue Hong, Yong Liu & Jing-Xin Li
Pages: 419-431
Published online: 02 Apr 2024
AbstractforImmunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 476 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
Gabiria Pastore, Jacopo Polvere, Fabio Fiorino, Simone Lucchesi, Giorgio Montesi, Ilaria Rancan, Sara Zirpoli, Arianna Lippi, Miriam Durante, Massimiliano Fabbiani, Mario Tumbarello, Francesca Montagnani, Donata Medaglini & Annalisa Ciabattini
Pages: 432-444
Published online: 02 Apr 2024
AbstractforHomologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant | Full Text | References | PDF (5.7 MB) | EPUB
  • 507 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
The important lessons lurking in the history of meningococcal epidemiology
Ray Borrow & Jamie Findlow
Pages: 445-462
Published online: 04 Apr 2024
AbstractforThe important lessons lurking in the history of meningococcal epidemiology | Full Text | References | PDF (3.5 MB) | EPUB
  • 738 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Plain Language Summary of Publication

Plain Language Summary of Publication
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary
Shanti Pather, Alexander Muik, Ruben Rizzi & Federico Mensa
Pages: 463-466
Published online: 05 Apr 2024
AbstractforDeveloping variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary | Full Text | PDF (240.3 KB) | EPUB
  • 576 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen
Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee & Jessica Weaver
Pages: 467-473
Published online: 09 Apr 2024
AbstractforPotential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen | Full Text | References | PDF (874 KB) | EPUB | Supplemental
  • 1009 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Anti-neuraminidase immunity in the combat against influenza
Xiaojian Zhang & Ted M. Ross
Pages: 474-484
Published online: 23 Apr 2024
AbstractforAnti-neuraminidase immunity in the combat against influenza | Full Text | References | PDF (3.2 MB) | EPUB
  • 436 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet & Kazumasa Kamei
Pages: 485-497
Published online: 02 May 2024
AbstractforCost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 171 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study
Rong Tang, Ying Zeng, Yu Zhou, Qi Liang, Wei Kang, Zhonghua Yang, Xiaoxiang Zheng, Xia Zang, Hongxing Pan, Jing Jin & Fengcai Zhu
Pages: 498-509
Published online: 02 May 2024
AbstractforSafety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study | Full Text | References | PDF (4.2 MB) | EPUB | Supplemental
  • 133 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Comment
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies
Timo Ulrichs, Morgane Rolland, Jianhong Wu, Marta C Nunes, Clotilde El Guerche-Séblain & Ayman Chit
Pages: 510-522
Published online: 06 May 2024
AbstractforChanging epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies | Full Text | References | PDF (354 KB) | EPUB
  • 314 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Accelerate vaccine development using seamless phase 2/3 trial designs
Jia-Ying Yang, Guo-Chun Li & Ying Yuan
Pages: 523-534
Published online: 07 May 2024
AbstractforAccelerate vaccine development using seamless phase 2/3 trial designs | Full Text | References | PDF (8 MB) | EPUB | Supplemental
  • 110 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Special Report

Report
The zebrafish as a potential model for vaccine and adjuvant development
Peter J. Hotez, Maria Elena Bottazzi, Nelufa Yesmin Islam, Jungsoon Lee, Jeroen Pollet, Cristina Poveda, Ulrich Strych, Syamala Rani Thimmiraju, Nestor L. Uzcategui, Leroy Versteeg & Daniel Gorelick
Pages: 535-545
Published online: 09 May 2024
AbstractforThe zebrafish as a potential model for vaccine and adjuvant development | Full Text | References | PDF (1,014.2 KB) | EPUB
  • 349 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

The zebrafish as a potential model for vaccine and adjuvant development
Peter J. Hotez et al.
Report | Published online: 9 May 2024
Open Access
Accelerate vaccine development using seamless phase 2/3 trial designs
Jia-Ying Yang et al.
Article | Published online: 7 May 2024
Open Access
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies
Timo Ulrichs et al.
Comment | Published online: 6 May 2024
Open Access
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
Shigeki Nakamura et al.
Article | Published online: 4 May 2024
Open Access
View all latest articles